e:Med

has the objective of promoting system-oriented research of diseases by linking life sciences and informatics and establishing a systems medicine network in Germany.

e:Med

has the objective of promoting system-oriented research of diseases by linking life sciences and informatics and establishing a systems medicine network in Germany.

e:Med

has the objective of promoting system-oriented research of diseases by linking life sciences and informatics and establishing a systems medicine network in Germany.

e:Med

has the objective of promoting system-oriented research of diseases by linking life sciences and informatics and establishing a systems medicine network in Germany.

A systems medicine network

e:Med has the objective of establishing systems medicine in Germany. e:Med promotes system-oriented research into diseases in order to facilitate improved prevention, more comprehensive diagnostics and individually adjusted therapy schemes in individualized medicine. The program brings together scientists with molecular-genetic, clinical, mathematical and information technology expertise, with the objective of ensuring that research results quickly benefit patients.
Electronic processing (e:Med) plays a particularly important role for unraveling scientific questions in iterative cycles of experimental studies and computer modelling approaches. The nationwide research and funding concept has been funded by the Federal Ministry of Education and Research (BMBF) since 2014.

Events and Highlights

Junior Research alliances

Stressed cancer cells resist treatment

Resistance of cancer cells against therapeutic agents is a major cause of treatment failure, especially in recurrent diseases. An international team of researchers in the e:Med junior research alliance SUPR-G has identified a novel mechanism of chemoresistance which has now been published in ‘Nature Communications’. It is driven by the Unfolded Protein Response (UPR), a cellular stress response pathway that alters gene expression and cellular metabolism to promote cell survival under stress.

read more

Systems Medicine

Systems Medicine against Corona

Systems medicine can help to better understand the novel corona virus and the pandemic. Substantial contributions have already been made with systems medicine methods: from the automated search for drug candidates against COVID-19, the simulation of infections or the return to normality to the examinations of which cells are preferably infected and why.
Here you find a selection of corona research activities by system medicine researcher - especially by e:Med scientists.

read more

e:Med

Young talents from the e:Med community

At the beginning of 2020, seven new junior research alliances in e:Med Module IIIb "Junior systems medicine research alliances" were launched by the support of the BMBF. In system-oriented research approaches, young scientists work on interdisciplinary medical issues relating to different types of cancer, chronic kidney disease or intestinal inflammation as well as metabolic or connective tissue diseases.

e:Med

New e:Med Alliances

The nine interdisciplinary research alliances of the e:Med Module I started at the end of 2019/beginning of 2020 with the support of the BMBF. In numerous sub-projects at different locations all over Germany, a common disease-related problem is being studied using systems medicine research approaches. Clinical working groups, high-throughput teams from basic biomedical research and experts in information technologies are working closely together on this.

e:Med

POSTPONED: e:Med Kick-off Meeting

Please note: The e:Med Kick-off Meeting 2020 in Bonn is postponed. It will take place later this year. Further information can be found on the meeting website.

e:Med

Four new Demonstrators started

Four new interdisciplinary demonstrator research networks started in the middle/end of 2019 in the e:Med Module II Demonstrators for Individualised Medicine. They are initially funded by the BMBF with 8.3 million EUR. The concrete goal of the new demonstrators is the system-oriented (further) development of innovative methods and models in order to use them directly in the individualised prevention, diagnostics and therapy of human diseases such as chronic kidney disease (NephrESA), B-cell lymphoma (SeneSys), chronic inflammatory bowel diseases (GUIDE-IBD) and addictions such as alcohol dependence (Target-OXY).

e:Med

Researcher`s Night

On Friday, September 27, 2019, the European Researchers‘ Night, an EU-funded initiative took place in Heidelberg / Mannheim. The e:Med Systems Medicine office was particularly well received by young visitors with their offer: their own name could be converted into the DNA code to make a very personal pearl bracelet.

Consortia

From basic research to drug precursors

Scientists from the e:Med alliance SMOOSE at the Technical University of Dortmund, in cooperation with physicians from Essen and Bochum, succeeded in producing a new AKT inhibitor, which is already showing initial efficacy against pancreatic cancer. The scientists succeeded in determining the first crystal structure of the complex of AKT1 with the new covalent alllosteric AKT inhibitor Borussertib, which provided important insights into the structural basis of the inhibition.

  •                                                      ...all highlights